MEDICALLY GUIDED WEIGHT MANAGEMENT
Weight Management Options,
Personalized for You.
Explore prescription and medically guided treatment options selected according to your individual needs, goals, and provider evaluation.
Treatment options and eligibility are determined by a medical provider.
TREATMENT OPTIONS
Treatment Options, Guided by Your Provider.
Our medical team evaluates your individual needs, health history, and goals to determine which treatment option may be appropriate for you.
PRESCRIPTION
Phentermine & Phendimetrazine
Short-Term Weight Management Support
Phentermine and phendimetrazine are prescription appetite-support medications that may be used short term as part of a medically supervised weight management program.
These medications are intended to complement a broader plan that may include nutrition, physical activity, behavioral changes, and ongoing medical guidance.
Available Options:
Phentermine
15 mg · 30 mg · 37.5 mg
Phendimetrazine
35 mg
Medication selection, dosing, and eligibility are determined by a medical provider based on individual health history and treatment needs.
COMPOUNDED GLP-1
Compounded Semaglutide
GLP-1 Receptor Agonist
What Is It?
Semaglutide is a GLP-1 receptor agonist administered as a once-weekly injection that works with a pathway involved in appetite regulation and calorie intake.
How It Works?
By activating GLP-1 receptors, semaglutide can help reduce hunger and calorie intake, promote feelings of fullness, and slow gastric emptying.
What Makes It Different?
Semaglutide targets the GLP-1 receptor alone, offering a single-receptor approach focused on appetite regulation and satiety.
COMPOUNDED DUAL-INCRETIN
Compounded Tirzepatide
GIP + GLP-1 Receptor Agonist
What Is It?
Tirzepatide is a once-weekly dual-incretin injection that activates both GIP and GLP-1 receptors involved in appetite, food intake, and metabolic regulation.
How It Works?
By activating both GIP and GLP-1 receptors, tirzepatide can help reduce appetite and calorie intake while also supporting glucose-dependent metabolic responses and delaying gastric emptying.
What Makes It Different?
Tirzepatide works through two receptor pathways—GIP and GLP-1. This dual-receptor action is the key difference between tirzepatide and semaglutide.
Personalized Medical Guidance
Treatment selection and dosing are determined by a medical provider based on individual health history, needs, goals, and response to treatment.
EMERGING THERAPY
Retatrutide
Investigational Triple Agonist
GIP • GLP-1 • Glucagon
What Is It?
Retatrutide is an investigational once-weekly triple hormone receptor agonist currently being studied for obesity, weight management, and related metabolic conditions. It activates three receptor pathways: GIP, GLP-1, and glucagon.
How It Works?
By targeting three hormone receptor pathways simultaneously, retatrutide is being studied for its effects on appetite, food intake, energy expenditure, and metabolic regulation.
What Makes It Different?
Semaglutide acts primarily through the GLP-1 pathway, while tirzepatide targets GIP + GLP-1. Retatrutide adds a third pathway—glucagon—creating its triple-agonist mechanism.
Retatrutide is investigational and is not currently FDA-approved.
SUPPORTIVE CARE
Supportive Prescription Medications
Certain prescription medications may be considered to support individual needs during a medically supervised weight management program.
PRESCRIPTION DIURETIC
Hydrochlorothiazide
Water Pill / Fluid Management
What Is It?
Hydrochlorothiazide is a prescription thiazide diuretic, commonly referred to as a “water pill.” It works by helping the body remove excess sodium and water through increased urine production.
In Our Program
For appropriate patients, a medical provider may consider hydrochlorothiazide when fluid retention is a concern. It is not intended as a fat-loss medication and is not appropriate for every patient.
Provider Evaluation
Use is determined individually based on medical history, current medications, health status, and provider evaluation.
Prescription use is subject to medical evaluation and eligibility.
PRESCRIPTION ANTIEMETIC
Ondansetron
Nausea & Vomiting Support
What Is It?
Ondansetron is a prescription anti-nausea medication that works by blocking certain serotonin (5-HT3) receptors involved in nausea and vomiting.
In Our Program
During a medically supervised weight management program, a provider may consider ondansetron when nausea management is clinically appropriate.
Provider Evaluation
The need for supportive medication is evaluated individually based on symptoms, treatment plan, medical history, and provider assessment.
Prescription use is subject to medical evaluation and eligibility.
HCG PROGRAM
hCG Weight Management Program
Medically Supervised. Structured Around You.
Our hCG program is designed as a structured weight management approach that combines scheduled hCG injections, individualized nutrition guidance, and ongoing medical supervision.
01 — Personalized Plan
Your medical provider reviews your health history, goals, and treatment needs before creating your program.
02 — Active Treatment Phase
Patients follow their prescribed injection schedule along with a provider-directed reduced-calorie nutrition plan.
03 — Maintenance
After the active phase, the focus shifts toward maintaining progress and building sustainable nutrition habits.
Individualized Medical Guidance
Every hCG program is personalized. Treatment schedule, duration, and nutrition recommendations may vary based on individual needs and provider evaluation.
No hCG drug product is FDA-approved for weight loss. Program eligibility and treatment recommendations are determined by a medical provider.